Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-01-28

Clinical Trial Update: Phase 1 Trial of Inactivated West Nile Virus Vaccine [Phase 1]

View source ↗

Summary

A Phase 1 trial of an inactivated West Nile virus vaccine sponsored by NIAID has completed. This update notes the study status but does not provide efficacy dat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Inactivated West Nile virus vaccine

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: West Nile Viral Infection | Phase 1 | Status: COMPLETED